This analysis revealed upregulation of ERBB growth factor signaling to cancer cells post treatment, with increased communications received via all ERBB growth factor receptors (EGFR/ERBB1, HER2/ERBB2, HER3/ERBB3, and HER4/ERBB4) (Fig. 2D). This evidence concerns the gene ERBB2 and cancer.